# Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma

> **NCT00001909** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (—)

## Conditions studied

- Asthma
- Hypersensitivity

## Interventions

- **DRUG:** Soluble recombinantly produced IL-4R

## Key facts

- **NCT ID:** NCT00001909
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** —
- **Final completion:** 2000-05
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001909, "Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00001909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*